Westlake Chemical Partners Q3 profit rises on higher output, sales volume

By Reuters News


Overview

  • U.S. ethylene producer's Q3 revenue declined and missed sole analyst estimate

  • Net income attributable to partnership rose yr/yr on higher sales volume, lower maintenance capex

  • Company declared 49th consecutive quarterly distribution of $0.4714 per unit


Outlook

  • Company expects earnings and cash flows to benefit from stable ethylene sales agreement with Westlake


Result Drivers

  • HIGHER SALES VOLUME - Co said increased production and sales volume contributed to higher net income and distributable cash flow

  • LOWER MAINTENANCE CAPITAL EXPENDITURES - Co attributed increase in distributable cash flow and coverage ratio to reduced maintenance capex


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Miss

$261.90 mln

$336.30 mln (1 Analyst)

Q3 EPS

$0.46

Q3 Net Income Attributable

$16.2 mln

Q3 EBITDA

$128.33 mln

Q3 Gross Profit

$103.90 mln

Q3 Income from Operations

$95.56 mln


Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the commodity chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Westlake Chemical Partners LP is $26.00, about 19.4% above its November 3 closing price of $21.78

  • The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 12 three months ago


Reuters Recommended Reads

  • Nov 3 - ADM lifts FY adjusted EPS profit outlook after Q3 beat

  • Nov 3 - Ovintiv Q3 profit rises on higher energy prices, lower costs

  • Nov 3 - MPLX Q3 adjusted EBITDA slightly beats estimates on natgas, NGL growth


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.